SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (3795)12/17/1997 11:15:00 AM
From: Tunica Albuginea  Read Replies (2) of 23519
 
BigKNY3,

I bought this AM at the open at $10 1/8, three times my current long position, so that I am up 300% in my overall long position with great cost averaging down.
I feel comfortable from here on.
I will continue to add periodically if stock goes down.
I think the stock is very oversold because of an unfortunate coincidence of events that have been well described in this thread and of which everybody is well aware off
My feelings about the different issues-

=I can understand the shortfall in earnings.

This is a new co. When you try and jump as many hoops as this Co has in such a short period of time with a stock having a beta of........???? gggg, I will cut 'em some slack.

=insider selling.
It's less than in previous months.Everybody else i other companies has done it recently;I've looked at some recent stats .

=Italy study.
Muse was never developed to compare with the needle.Those needing the needle are termoinal cases of ED.
ON THE OTHER HAND, take a look at the Nov '97 issue of the American Jour of Urol were there is a nice study, again comparing Muse to the needle and they find a 35% response!!! I think that is pretty good considering that needle users are harder cases.
The question is how would Viagra have done in these two studies: I feel , worse than Muse.
I think I have addressed the most pertinent questions.

=Meanwhile in my neighbouhood the drug is beeing sold.There is at least a 40% refill rate.What I thought was significant is that the pharmacist I meet at the gym, tlls me that he has 4 physicians taking mUse now.
I think that when all the ducts are lined up this baby is going to sell like gang busters.
When you invest you HAVE to buy when nobody wants it, gg.
I remember Micron Tech at 18 until T Kurlak reccommended it at 22 and in 5 months went to 52?It had languished at 18-22 for ?5 months and then it shot up. And so many more.
I just got snookered on my 16 year old son'rs favorite stock, TDFX,
they make 3D PC games.He sais " dad they have great technology".
Kid knows what he is taliking about Re computer games, that's his hobby.TDFX came out 4 months ago at 8 went to 18 and my son bought it at 16. I bought and sold a couple of trades, made a few bucks and then got out of it. Stock DRIFTED down to 13.5 , from lack of news.My son is down $1500, all his savings.He said " I am not selling; this is an investment; it wil go up".And it did , with a sudden anniuncement that sales were going to be 50% better than expected.
Stock went to 22.5; I bought in at 21, 5 days after I could have had it for 13.5!!
So I bought Vivus. I think they have a good product for ED. You may not get an iron out of it, but it allows you to have intercourse.That is better than previous zero intercourse.They'll come out with Prazosin-Muse which will be better;possibly other local therapy( I like Forskolin ). Combined with Viagra I think you'll have a better hard.
35% efficacy out of 200 mill world wide ED cases X $10-20/dose=
a lot of earnings.
For all we know, Vinick may be buying now.

Good luck.

TA
PS By the wayy I think the market will move up because Japan cut it's taxes.That is the key to growth out of their slump: give people backTHEIR money and let them spend it ( on Muse, gg ).
Jan 1st, a giant cash flow will begin again and off we go.
It's always dark before dawn.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext